Skip to main content

Perioperative liberal versus restrictive fluid strategies and postoperative outcomes: a systematic review and metanalysis on randomised-controlled trials in major abdominal elective surgery

Abstract

Background

Postoperative complications impact on early and long-term patients’ outcome. Appropriate perioperative fluid management is pivotal in this context; however, the most effective perioperative fluid management is still unclear. The enhanced recovery after surgery pathways recommend a perioperative zero-balance, whereas recent findings suggest a more liberal approach could be beneficial. We conducted this trial to address the impact of restrictive vs. liberal fluid approaches on overall postoperative complications and mortality.

Methods

Systematic review and meta-analysis, including randomised controlled trials (RCTs). We performed a systematic literature search using MEDLINE (via Ovid), EMBASE (via Ovid) and the Cochrane Controlled Clinical trials register databases, published from 1 January 2000 to 31 December 2019. We included RCTs enrolling adult patients undergoing elective abdominal surgery and comparing the use of restrictive/liberal approaches enrolling at least 15 patients in each subgroup. Studies involving cardiac, non-elective surgery, paediatric or obstetric surgeries were excluded.

Results

After full-text examination, the metanalysis finally included 18 studies and 5567 patients randomised to restrictive (2786 patients; 50.0%) or liberal approaches (2780 patients; 50.0%). We found no difference in the occurrence of severe postoperative complications between restrictive and liberal subgroups [risk difference (95% CI) = 0.009 (− 0.02; 0.04); p value = 0.62; I2 (95% CI) = 38.6% (0–66.9%)]. This result was confirmed also in the subgroup of five studies having a low overall risk of bias. The liberal approach was associated with lower overall renal major events, as compared to the restrictive [risk difference (95% CI) = 0.06 (0.02–0.09); p value  = 0.001]. We found no difference in either early (p value  = 0.33) or late (p value  = 0.22) postoperative mortality between restrictive and liberal subgroups

Conclusions

In major abdominal elective surgery perioperative, the choice between liberal or restrictive approach did not affect overall major postoperative complications or mortality. In a subgroup analysis, a liberal as compared to a restrictive perioperative fluid policy was associated with lower overall complication renal major events, as compared to the restrictive.

Trial Registration

CRD42020218059; Registration: February 2020, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=218059.

Introduction

A worldwide effort aims to reduce postoperative complications[1], which are recognised as partially preventable events affecting long-term morbidity and impacting health and financial systems [2, 3]. Several perioperative strategies have been proposed to optimise intraoperative management and postoperative care [4]. Among them, perioperative fluid therapy is a core concept. The ideal perioperative approach has been debated for decades, having the crucial role of balancing oxygen supply and demand, maintaining fluid and electrolyte homeostasis and avoiding inadequate tissue perfusion and fluid overload [5,6,7,8,9,10,11,12].

The most effective perioperative fluid management is still unclear [13,14,15]. It has been classified as restrictive (< 1.75 L per day), balanced (1.75 to 2.75 L per day) and liberal (> 2.75 L per day)[16]. However, the literature provides different, somewhat overlapping definitions (i.e. from 1.0 to 2.7 L for restrictive, compared with 2.8 to 5.4 L for liberal fluid regimens) [17] and conflicting evidence [13,14,15]. The enhanced recovery after surgery (ERAS) pathways to support early recovery among patients undergoing major surgery recommend a restrictive approach aiming at the perioperative “zero-balance”[13]. In contrast, recent findings suggest that excessively restrictive approaches could be detrimental, indicating that a moderately liberal fluid regimen (i.e. positive fluid balance of 1 to 2 L at the end of surgery) might be the best approach[14].

Interestingly, a recent large randomised controlled trial (RCT) assigning 2983 patients to either zero-balance or liberal strategy showed comparable disability-free survival outcome, although the zero-balance approach was associated with a higher rate of acute kidney injury [16]. As a matter of fact, this single study enrolled more patients than several previous RCTs regarding this topic, insofar, partially challenging previous results [18,19,20].

Therefore, we conducted an up-to-date meta-analysis of RCTs to assess the association between restrictive and liberal strategies and major adverse surgical outcomes in elective surgery.

Secondarily, we appraised the association between restrictive and liberal approaches on perioperative mortality, predefined postoperative organ-related complications and hospital length of stay. Finally, we stratified the studies according to preoperative severity score and the reported rate of complications [i.e. American Society of Anaesthesiologists (ASA) physical status score].

Materials and methods

We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis—Protocols (PRISMA-P) guidelines [21] (Additional file 1: Table 1) and the study protocol was registered [(International Prospective Register of Systematic Reviews—PROSPERO (CRD42020218059)].

Data sources and search strategy

A systematic literature search was performed by using the following databases to identify relevant studies in indexed scientific journals: MEDLINE (via Ovid), EMBASE (via Ovid) and the Cochrane Controlled Clinical trials register, by using the terms: [(“liberal” OR “restrictive” OR “zero-balance” AND (“surgery”/exp OR surgery)] with filters for humans, age (< 18 years), language (English) and time of publication (1 January 2000 to 31 December 2019).

We included RCTs 1) enrolling adult patients undergoing elective abdominal surgery; 2) comparing two different regimes of fluid administration defined as “restrictive” and “liberal” or “conventional” or “standard”; 3) starting the study protocol intraoperatively; 4) reporting postoperative complications or mortality or as primary or secondary outcomes.

The restrictive approach was defined as a modality of perioperative (i.e. intraoperative and during the first 24 h after surgery) treatment employing a specific and predefined treatment protocol to obtain in one of the enrolled populations an overall negative or zero fluid balance, as compared to the other. Accordingly, trials showing no statistically significant difference in the overall fluid intake or balance, between restrictive and liberal subgroups, were also excluded.

Studies involving cardiac, non-elective surgery, paediatric or obstetric surgeries were excluded. We also excluded editorials, commentaries, letters to the editor, opinion articles, reviews, meeting abstracts and original articles lacking abstract and/or quantitative details, or those enrolling less than 15 patients in each subgroup.

The references of all included papers, review articles, commentaries and editorials on this topic were also reviewed to identify other studies of interest missed during the primary search.

Data extraction and quality assessment

Three couples of examiners (S.S., E.M., D.B., F.I., M.B., G.D.M.) independently evaluated titles and abstracts. The articles were then subdivided into three subgroups: “included” and “excluded” (if the two examiners agreed with the selection) or “uncertain” (in case of disagreement). In the case of “uncertain” classification, discrepancies were resolved by further examination performed by two expert authors (A.M. and C.R.). We used a standardised electronic spreadsheet (Microsoft Excel, V 14.4.1; Microsoft, Redmond, WA) to extract the data from all included studies, recording trial characteristics (the complete data reporting sheet is provided in Additional file 1: Table 2). When necessary, the included studies’ corresponding authors were contacted to obtain missing data related to trial demographics, methods and outcomes.

Risk of bias assessment in the included studies

Two examiners (L.C. and D.Z.) independently assessed the internal validity of the included studies and discrepancies were resolved by a third senior author (A.M. or C.R.), by using the RoB 2 (a revised Cochrane Collaboration’s risk of bias tool for randomised trials) [22]. The RoB 2 considers five bias domains: 1) the randomisation process; 2) the deviations from intended interventions; 3) missing outcome data; 4) measurement of the outcome; 5) selection of the reported results. Finally, the overall risk of bias was calculated and, accordingly, studies were included in either high-risk/ some concerns /low-risk groups.

The strength of the body of evidence

The strength of the body of evidence was assessed according to the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) evidence system[23].

Outcomes definitions

Our primary outcome was to appraise the effect of restrictive vs liberal approaches on the overall rate of major complications. This outcome was assessed both considering all the studies reporting it, and those in the subgroup having a low-risk of bias, according to the RoB 2 scale.

Secondary outcomes were: to evaluate the association between restrictive and liberal approaches on perioperative early (≤ 30 postoperative days) and late (i.e. > 30 postoperative days) mortality and predefined postoperative major complications: renal (i.e. worsening of renal function, according to the trial definition); cardiovascular [i.e. pulmonary not infective complications, cardiac ischemic dysfunction/failure, cardiac arrhythmias; acute neurological events); infections (i.e. all infective complications reported, including the occurrence of either sepsis or septic shock). We also evaluated the length of hospital stay and stratified the studies according to the enrolled patients’ ASA classification.

Statistical analysis

Statistical analysis was conducted on the summary statistics described in the selected articles (e.g. means, medians, proportions) and, therefore, the statistical unit of observation for all the selected variables was the single study and not the patient. Descriptive statistics of individual studies used different statistical indicators for central tendency and variability, such as means and standard deviations, whereas absolute and relative frequencies were adopted for qualitative variables. To show one single indicator for the quantitative variables we collected means with standard deviations (SD) or medians and inter-quartile ranges (IQR) were used, as appropriate.

The metanalysis included only those studies reporting mortality and rate of complications, according to the definition adopted in each study and expressed as rate with respect of the enrolled populations. For ASA subgroup analysis, we grouped studies with at least 50% of the included population classified as ASA I/II, compared to those having at least 50% of the included population classified as ASA III/IV. We, finally, stratified the studies according to three tertiles of the overall amount of perioperative fluid given (day 0 and day 1) and the rate of major events.

We assessed publication bias using a funnel plot for the considered outcomes. Statistical heterogeneity and inconsistency were measured using Q and I2 tests and were deemed to be significant when p < 0.1 and I2 > 50%. According to heterogeneity, random or fixed-effect models were used to perform metanalysis. According to Higgins et al. [24], I2 values around 25, 50 and 75% were considered representing, respectively, low, moderate and severe statistical inconsistency.

The statistical software STATA®13 (StataCorp, College Station, TX, USA) was used to perform all the computations.

Results

We identified 26 potentially eligible studies after the title and abstract assessment (Fig. 1 and Additional file 1: Table 3). After full-text examination, the metanalysis finally included 18 studies and 5567 patients (male/female ratio 1.1:1) randomised to restrictive (2786 patients; 50.0%) and liberal approaches (2780 patients; 50.0%). All the studies, except one [25], have been conducted on non-obese patients, the vast majority being scheduled for laparotomic (3925 patients, 70.5%) surgery. All the studies, except two [25, 26], were conducted on patients with a median age > 60 years old (Table 1). Interestingly, in 5 studies (27.7%), including the largest one [16], the perioperative fluid administration algorithm was guided by the optimisation of predefined or flow haemodynamic pressure variables, by means of a goal-directed therapy [16, 25, 27,28,29] (Additional file 1: Table 4).

Fig. 1
figure 1

Flow of the studies. * = Not fitting eligibility criteria full-text articles excluded are reported in Additional file 1: Table 3. ROB, risk of bias

Table 1 Summary of the included studies: general characteristics of the enrolled population

The risk of bias assessment reported: “low risk” for 8 (44.4%) and “some concerns” for 11 10 (55.5%) of the included studies, mostly (9 of these 11; 81.8%) related to the selection of the reported results (Fig. 2).

Fig. 2
figure 2

The internal validity of the included studies was assessed by two expert authors, by using the Rob2: a revised Cochrane Collaboration’s risk of bias tool for randomised trials [22]

Following the GRADE system, the quality of evidence was defined as high for 8 studies [16, 25, 30,31,32,33,34,35] and moderate for all the others.

Perioperative fluid administration, balance and weight gain

Intraoperatively, patients in the restrictive subgroup overall received a median (IQR) of 1925 (1482–2470) of fluids, as compared to 3878 (3000–4400) of the liberal subgroup. On day 0 (i.e. considering the overall amount of fluids received on the day of the operation, including intraoperative fluid therapy), patients in the restrictive subgroup overall received a median (IQR) of 2341 ml (1635–3530) of fluids, as compared to 4,350 ml (3095–5326) in the liberal subgroup. Finally, considering day 0 and day 1, a median of 3617 (2897–5291) of fluids was administered to the restrictive subgroups, as compared to 5820 (5038–7000) to the liberal subgroups (Table 2 and Additional file 1: Table 4).

Table 2 Summary of the included studies: fluid infused on day 0 and day 1

Only two studies reported the mean postoperative overall fluid balance among restrictive and liberal subgroups [16, 33]. Nine studies (50.0%) did not report postoperative weight gain [25, 26, 29,30,31, 33, 34, 36, 37], moreover, in Myles et al.’s study, data regarding this variable were missing for 1,036 (69.5%) patients in the restrictive fluid group and 999 (66.9%) in the liberal fluid group [16].

Five studies (27.7%) [16, 28, 35, 38, 39] reported a median (IQR) weight gain of 0.3 kg (− 0.1 to 0.65) and 2.0 kg (1.7–2.6) in restrictive and liberal groups on postoperative day 1, respectively.

Primary outcome: rate of major complications

Pooling data from the 13 studies, we found no difference in the occurrence of major postoperative complications between restrictive and liberal subgroups [pooled risk difference (95% CI) = 0.009 (− 0.02; 0.04); Chi2 = 0.24; p value  = 0.62; I2 (95% CI) = 38.6% (0–66.9%)] (Fig. 3). In the subgroup of five studies [16, 25, 30,31,32] reporting the outcome of major postoperative events and having a low overall risk of bias, we found no difference between restrictive and liberal subgroups [pooled risk difference (95% CI) = 0.013 (−0.02; 0.05); Chi2 = 0.42; p value  = 0.51; I2 (95% CI) = 1.0% (0–64.5%)].

Fig. 3
figure 3

Forest and bias assessment plots of postoperative major events

Secondary outcomes

Postoperative mortality

We found no difference in either early [data pooled from the 10 studies—pooled risk difference = − 0.005 (95% CI − 0.016 to 0.005); Chi2 = 0.95; p value  = 0.33; I2 = 0% (95% CI 0% to 52.7%)] or late [data pooled from the 8 studies—pooled risk difference = 0.005 (95% CI − 0.003 to 0.012); Chi2 = 1.51; p value  = 0.22; I2 (inconsistency) = 0% (95% CI 0–56.3%)] postoperative mortality between restrictive and liberal subgroups (Additional file 1: Figures 1–2).

Postoperative organ-related major complications and length of stay

Pooling data from the 8 studies, the liberal approach was associated with lower overall complication renal major events, as compared to the restrictive [pooled risk difference (95% CI) = 0.06 (0.02–0.09); Chi2 = 10.3; p value  = 0.001] (Fig. 4). In this subgroup, a sub-analysis regarding the use of type of fluid used intraoperatively (colloids vs. crystalloids) showed a borderline statistical significance regarding an increased incidence of major renal events in the restrictive populations receiving colloids, as compared to the liberal ones [mean (SD) major renal events 8.0% (4.7) vs. 1.7% (1.9); p = 0.05].

Fig. 4
figure 4

Forest and bias assessment plots of postoperative major renal events

On the contrary, we found no difference between restrictive and liberal subgroups in the occurrence of either severe postoperative cardiovascular (9 studies; p value  = 0.88) or infective (10 studies; p value  = 0.10) complications (Additional file 1: Figures 3–4), or the length of hospital stay [7 days (6–9) vs. 7 days (5–8); p value  = 0.49].

Subgroup analyses

As reported in Additional file 1: Table 5, preoperative ASA risk score did not impact the postoperative complications rate, among restrictive/liberal subgroups. No difference in the overall rate of major complications was found by stratifying the in tertiles of overall perioperative fluid administered (Fig. 5).

Fig. 5
figure 5

Liberal / restrictive classification of the subgroups of patients in the included studies. Data are reported according to the tertiles of overall fluid amount (in ml) reported in the days 0 (day of the operation) and 1 (first postoperative day)

Discussion

This metanalysis conducted on RCTs in major abdominal elective surgery regarding the effect of perioperative liberal or restrictive approach on postoperative outcomes found no difference between the two approaches in the occurrence of the overall major postoperative complications or mortality. On the contrary, the liberal fluid policy was associated with lower overall complication renal major events, as compared to the restrictive.

Postoperative complications are common after major surgery and represent a significant financial and social burden [2, 3]. Optimisation of fluid management has been extensively studied as a potentially modifiable perioperative factor by adopting specific protocols focused on modality of fluid administration and cumulative fluid balance [9,10,11, 40]. The analysis of the literature in this field is rather complex due to the number of variables potentially affecting the final outcomes, which includes the overall complexity and the intrinsic risks of each specific type of the surgery.

On the one hand, a tendency towards a more restrictive approach (as supported by the ERAS pathways [13]) has been reported. In fact, a previous metanalysis [19] showed that fewer patients had a lower total complication rate and risk of infection in the restrictive group as compared to the liberal group.

On the other, the recent large RCT performed by Myles et al. challenged this concept, showing that disability-free survival at 1 year did not change in patients randomised to a zero-balance vs a liberal approach, with the first strategy being associated with higher rates of acute kidney injury, surgical site infection and need for renal-replacement therapy [16]. Interestingly, this single trial enrolled more patients than 17 RCTs combined in the previous 15 years (Table 1). The weight of this trial specifically impacts on postoperative major renal events of the present metanalysis, which were lower in the liberal subgroup as compared to the restrictive (Fig. 4). Interestingly, renal events did not impact on overall mortality, despite the fact that acute kidney injury is recognised as an independent risk factor for mortality [41]. However, postoperative mortality is greatly affected by the results of the study of Myles et al. [16]. Moreover, the present metanalysis did not include trials on cardiac surgery, which is a clinical setting specifically associated with an increased risk of death in those patients who develop postoperative acute kidney injury [41,42,43].

Considering the impact of crystalloids/colloids use on the renal postoperative outcome, this metanalysis only suggests a possible additive effect of the colloids use in a restrictive approach. However, a recent large RCT comparing the use of low molecular weight hydroxyethyl-starch vs. 0.9% saline for intravascular volume expansion in high-risk surgical patients showed no significant difference in a composite outcome of death or significant postoperative [27]. For this reason, this result should be considered with extreme caution.

In the field of perioperative fluid administration, summarising the evidence available in the literature into straightforward clinical suggestions for daily clinical practice is rather complicated, and our updated results basically indicate an equivalence between the two perioperative fluid policies, suggesting a “third way”. The overall amount of fluid (perioperative target) should be integrated into an individualised goal-directed fluid replacement strategy (perioperative policy), to prevent fluid overload and fluid shortage by closely monitoring the effects of each bolus administered, as long as the individual plateau of the impact on predefined flow or pressure variables is achieved [12, 44]. Interestingly, this approach was incorporated into the intraoperative protocol of 5 studies [16, 25, 27,28,29], including the study of Myles et al. who assessed central venous pressure and stroke volume variation in case of intraoperative hypotension to guide resuscitation (supplementary appendix of the trial [16]). Moreover, a recent metanalysis showed a trend towards the reduction of postoperative complications when a goal-directed therapy is used in patients receiving large amounts of perioperative fluids [45]. Thus, rather than choosing between a fixed-volume regimen and a goal-directed concept, an alternative approach could be to combine the two strategies. Of note, in the study of Myles et al. [16] restrictive fluid therapy had similar effects in patients treated with or without a goal-directed device.

As shown by our qualitative analysis, neither the perioperative intakes nor the fluid balance or the bodyweight gain has been consistently reported in the considered RCTs. Surprisingly, the overall fluid balance or the postoperative weight difference, which should be, in principle, the most effective perioperative variables depicting the fluid paths of restrictive and liberal subgroups, has been reported only in 5 studies (27.7%) [16, 33, 35, 46, 47]. The heterogeneity in actual overall fluid balance computation, as long the definition of postoperative complications (see further) greatly affects the comparability of the RCTs, soliciting clear standards in data reporting.

Considering the fluid intake alone, our data suggest that an overall median administration of about 4 L on days 0 and 1 may be considered restrictive, whereas about 6 L may be considered liberal. However, as pointed out by previous metanalysis [18, 19], these cut-offs are associated with large inter-quartile ranges due to the lack of consistency in perioperative fluid regimen definition. Consequently, some subgroups of RCTs classified as restricted would be considered liberal in some other trials (see Fig. 5), because of overlapping perioperative volumes.

However, despite the lack of statistical significance, we found the highest rates of major complications in the highest and lowest tertiles of our sub-analysis.

Finally, the included studies all report overall low perioperative mortality rates; thus, as expected, the impact of liberal vs. restrictive strategies on perioperative mortality was not significant.

Limitations

Some limitations of this study should be acknowledged.

First, as concern the data obtained from the included studies: 1) the definition of postoperative complications and the timing in mortality assessment may vary among the included studies, implying a bias in the reported outcomes’ comparability. In fact, some complications (i.e. pneumonia, wound abscess/infection/dehiscence, pneumothorax) have been considered either as minor or major, according to study-specific criteria, which have been respected in the data analysis; 2) we computed major/minor complications according to either the criteria adopted in the study or (only for subgroup analysis) definitions clearly indicating the gravity degree (i.e. peritonitis and anastomotic leak has been always considered as severe complications); 3) the impact of restrictive/liberal policies on specific subgroups of patients is overall lacking (i.e. patients with pre-existing renal or diastolic cardiac dysfunction), limiting the generalisability of data; 4) this is not a meta-analysis based on individual data and the main author of each study (whenever needed) has been contacted only to provide more specific information regarding the results on the overall population enrolled. This is specifically important for colloids/crystalloids sub-analysis.

Third, the overall quality of the included studies reported “some concerns” in the majority of them (55.5%), mostly related to the selection of the reported results due to drawbacks in the trial registration. This is mainly due to the criteria imposed by the RoB 2 scale [22] for the trial registration. The International Committee of Medical Journal Editors policy regarding prospective trial registration was started in 2005 [48], and most of the trial published before 2010 do not fulfil the RoB 2 criteria for “low-risk” report. Moreover, a monitoring of the study protocol is reported only in three studies [16, 26, 33].

Finally, we adopted a database combination search strategy, including PUBMED®, EMBASE® and the Cochrane Controlled Clinical trials register, excluding different sources (i.e. Web of Science®). Although this choice should allow a reliable coverage of the published studies for the topic of interest, some RCTs could not be identified.

Conclusions

In major abdominal elective surgery perioperative, the choice between liberal or restrictive approach did not affect overall major postoperative complications or mortality. In a subgroup analysis, a liberal fluid policy was associated with lower overall complication renal major events, as compared to the restrictive.

The lack of consistency in perioperative overall fluid balance and in the definitions of clinical outcomes still affects the comparability of the results of RTCs, soliciting clear standards in data reporting.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ASA:

American Society of Anaesthesiologists (ASA) physical status score

RCT:

Randomised controlled trial

ERAS:

Enhanced recovery after surgery

SD:

Standard deviation

95%CI:

95% Confidence intervals

References

  1. de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G, van Helden SH, et al. Effect of a comprehensive surgical safety system on patient outcomes. N Engl J Med. 2010;363:1928–37.

    Article  PubMed  Google Scholar 

  2. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326–41.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Healy MA, Mullard AJ, Campbell DA Jr, Dimick JB. Hospital and payer costs associated with surgical complications. JAMA Surg. 2016;151:823–30.

    Article  PubMed  Google Scholar 

  4. Kang SH, Lee Y, Min SH, Park YS, Ahn SH, Park DJ, et al. Multimodal enhanced recovery after surgery (eras) program is the optimal perioperative care in patients undergoing totally laparoscopic distal gastrectomy for gastric cancer: A prospective, randomized, clinical trial. Ann Surg Oncol. 2018;25:3231–8.

    Article  PubMed  Google Scholar 

  5. Holte K, Kehlet H. Fluid therapy and surgical outcomes in elective surgery: a need for reassessment in fast-track surgery. J Am Coll Surg. 2006;202:971–89.

    Article  PubMed  Google Scholar 

  6. Cecconi M, Corredor C, Arulkumaran N, Abuella G, Ball J, Grounds RM, et al. Clinical review: goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups. Crit Care. 2013;17:209.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011;112:1392–402.

    Article  PubMed  Google Scholar 

  8. Lobo SM, de Oliveira NE. Clinical review: What are the best hemodynamic targets for noncardiac surgical patients? Crit Care. 2013;17:210.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Marik PE. Perioperative hemodynamic optimization: a revised approach. J Clin Anesth. 2014;26:500–5.

    Article  PubMed  Google Scholar 

  10. Voldby AW, Brandstrup B. Fluid therapy in the perioperative setting-a clinical review. J Intensive Care. 2016;4:27.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Thacker JK, Mountford WK, Ernst FR, Krukas MR, Mythen MM. Perioperative fluid utilization variability and association with outcomes: considerations for enhanced recovery efforts in sample us surgical populations. Ann Surg. 2016;263:502–10.

    Article  PubMed  Google Scholar 

  12. Heming N, Moine P, Coscas R, Annane D. Perioperative fluid management for major elective surgery. Br J Surg. 2020;107:e56–62.

    Article  CAS  PubMed  Google Scholar 

  13. Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, et al. Guidelines for perioperative care in elective colonic surgery: Enhanced recovery after surgery (eras((r))) society recommendations. World J Surg. 2013;37:259–84.

    Article  CAS  PubMed  Google Scholar 

  14. Miller TE, Myles PS. Perioperative fluid therapy for major surgery. Anesthesiology. 2019;130:825–32.

    Article  PubMed  Google Scholar 

  15. Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, Serednicki WT, Jankowski M, Bala MM, et al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev. 2019;12:CD012767.

    PubMed  Google Scholar 

  16. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378:2263–74.

    Article  PubMed  Google Scholar 

  17. Bundgaard-Nielsen M, Secher NH, Kehlet H. “Liberal” vs. “Restrictive” perioperative fluid therapy—a critical assessment of the evidence. Acta Anaesthesiol Scand. 2009;53:843–51.

    Article  CAS  PubMed  Google Scholar 

  18. Bundgaard-Nielsen M, Secher NH, Kehlet H. “Liberal” vs. “Restrictive” perioperative fluid therapy—a critical assessment of the evidence: review article. Acta Anaesthesiol Scand. 2009;53:843–51.

    Article  CAS  PubMed  Google Scholar 

  19. Schol PBB, Terink IM, Lancé MD, Scheepers HCJ. Liberal or restrictive fluid management during elective surgery: a systematic review and meta-analysis. J Clin Anesth. 2016;35:26–39.

    Article  PubMed  Google Scholar 

  20. Pang Q, Liu H, Chen B, Jiang Y. Restrictive and liberal fluid administration in major abdominal surgery. Saudi Med J. 2017;38:123–31.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. BMJ. 2009;339:b2535.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

    Article  PubMed  Google Scholar 

  23. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ. 2008;336:1049–51.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Matot I, Paskaleva R, Eid L, Cohen K, Khalaileh A, Elazary R, et al. Effect of the volume of fluids administered on intraoperative oliguria in laparoscopic bariatric surgery: a randomized controlled trial. Arch Surg. 2012;147:228–34.

    Article  PubMed  Google Scholar 

  26. Kabon B, Akca O, Taguchi A, Nagele A, Jebadurai R, Arkilic CF, et al. Supplemental intravenous crystalloid administration does not reduce the risk of surgical wound infection. Anesth Analg. 2005;101:1546–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Futier E, Garot M, Godet T, Biais M, Verzilli D, Ouattara A, et al. Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the flash randomized clinical trial. JAMA. 2020;323:225–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology. 2005;103:25–32.

    Article  PubMed  Google Scholar 

  29. Kassim D, Esmat I. Goal directed fluid therapy reduces major complications in elective surgery for abdominal aortic aneurysm: Liberal versus restrictive strategies. Egypt J Anaesth. 2016;32:167–73.

    Article  Google Scholar 

  30. Gao T, Li N, Zhang JJ, Xi FC, Chen QY, Zhu WM, et al. Restricted intravenous fluid regimen reduces the rate of postoperative complications and alters immunological activity of elderly patients operated for abdominal cancer: A randomized prospective clinical trail. World J Surg. 2012;36:993–1002.

    Article  PubMed  Google Scholar 

  31. Grant F, Brennan MF, Allen PJ, DeMatteo RP, Kingham TP, D’Angelica M, et al. Prospective randomized controlled trial of liberal vs restricted perioperative fluid management in patients undergoing pancreatectomy. Ann Surg. 2016;264:591–8.

    Article  PubMed  Google Scholar 

  32. Kalyan JP, Rosbergen M, Pal N, Sargen K, Fletcher SJ, Nunn DL, et al. Randomized clinical trial of fluid and salt restriction compared with a controlled liberal regimen in elective gastrointestinal surgery. Br J Surg. 2013;100:1739–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lavu H, Sell NM, Carter TI, Winter JM, Maguire DP, Gratch DM, et al. The hyslar trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated ringers in patients undergoing pancreaticoduodenectomy. Ann Surg. 2014;260:445–53.

    Article  PubMed  Google Scholar 

  34. Piljic D, Petricevic M, Piljic D, Ksela J, Robic B, Klokocovnik T. Restrictive versus standard fluid regimen in elective minilaparotomy abdominal aortic repair-prospective randomized controlled trial. Thorac Cardiovasc Surg. 2016;64:296–303.

    PubMed  Google Scholar 

  35. Wuethrich PY, Burkhard FC, Thalmann GN, Stueber F, Studer UE. Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology. 2014;120:365–77.

    Article  CAS  PubMed  Google Scholar 

  36. Futier E, Constantin JM, Petit A, Chanques G, Kwiatkowski F, Flamein R, et al. Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: a prospective randomized trial. Arch Surg. 2010;145:1193–200.

    Article  PubMed  Google Scholar 

  37. Muller S, Zalunardo MP, Hubner M, Clavien PA, Demartines N. Zurich Fast Track Study G: a fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology. 2009;136:842–7.

    Article  PubMed  Google Scholar 

  38. Abraham-Nordling M, Hjern F, Pollack J, Prytz M, Borg T, Kressner U. Randomized clinical trial of fluid restriction in colorectal surgery. Br J Surg. 2012;99:186–91.

    Article  CAS  PubMed  Google Scholar 

  39. Holte K, Foss NB, Andersen J, Valentiner L, Lund C, Bie P, et al. Liberal or restrictive fluid administration in fast-track colonic surgery: a randomized, double-blind study. Br J Anaesth. 2007;99:500–8.

    Article  CAS  PubMed  Google Scholar 

  40. Messina A, Pelaia C, Bruni A, Garofalo E, Bonicolini E, Longhini F, et al.: Fluid challenge during anesthesia: a systematic review and meta-analysis. Anesth Analg 2018

  41. See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 2019;95:160–72.

    Article  PubMed  Google Scholar 

  42. Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017;13:697–711.

    Article  PubMed  Google Scholar 

  43. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444–53.

    Article  PubMed  Google Scholar 

  44. Kampmeier TG, Ertmer C. Individualized goal-directed therapy: The challenge with the fluids. Anesth Analg. 2020;130:596–8.

    Article  PubMed  Google Scholar 

  45. Messina A, Robba C, Calabrò L, Zambelli D, Iannuzzi F, Molinari E, et al. Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery. Crit Care. 2021;25:43.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: A randomized assessor-blinded multicenter trial. Ann Surg. 2003;238:641–8.

    Article  PubMed  PubMed Central  Google Scholar 

  47. van Samkar G, Eshuis WJ, Bennink RJ, van Gulik TM, Dijkgraaf MG, Preckel B, et al. Intraoperative fluid restriction in pancreatic surgery: a double blinded randomised controlled trial. PLoS ONE. 2015;10:e0140294.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the international committee of medical journal editors. N Engl J Med. 2004;351:1250–1.

    Article  PubMed  Google Scholar 

  49. Jie HY, Ye JL, Zhou HH, Li YX. Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer. World J Gastroenterol. 2014;20:15852–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None declared.

Funding

This work has not been funded by an external source.

Author information

Authors and Affiliations

Authors

Contributions

A.M. and C.R. designed the study, conducted the primary data search, solved the classification discrepancies in data collection and drafted the manuscript; L.C., D.Z., F.I., E.M., S.S., D.B. and M.B. performed the evaluation of titles and abstracts and helped in data collection and the manuscript preparation, L.S. and G.S. conducted the data analysis and helped in manuscript preparation; P.P. substantially contributed in manuscript preparation and data interpretation; M.C. helped in designing the study and in the primary search and substantially contributed in manuscript preparation and data interpretation. All the authors approved the final version of the paper and agree to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Antonio Messina.

Ethics declarations

Ethical approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Dr. Messina received travel expenses and registration for meetings, congresses, and courses and lecture fees from Vygon; Prof. Cecconi is a consultant for Edwards Lifesciences, LiDCO and Cheetah Medical.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

. Supplementary materials including supplementary tables and figures.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Messina, A., Robba, C., Calabrò, L. et al. Perioperative liberal versus restrictive fluid strategies and postoperative outcomes: a systematic review and metanalysis on randomised-controlled trials in major abdominal elective surgery. Crit Care 25, 205 (2021). https://doi.org/10.1186/s13054-021-03629-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13054-021-03629-y

Keywords